Giant Cell Glioblastoma
Also known as: Giant cell glioblastoma (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00853 | Temozolomide | 0 | Completed | 1 |
DB00041 | Aldesleukin | 1 | Completed | 1 |
DB17241 | Azurin-p28 | 1 | Completed | 1 |
DB15722 | CYNK-001 | 1 | Terminated | 1 |
DB05153 | Cabozantinib | 1 | Completed | 1 |
DB08875 | Cabozantinib | 1 | Completed | 1 |
DB17475 | Incomplete Freund's adjuvant | 1 | Completed | 1 |
DB00020 | Sargramostim | 1 | Completed | 1 |
DB00853 | Temozolomide | 1 | Completed | 1 |
DB17459 | Therapeutic allogeneic lymphocytes | 1 | Completed | 1 |
DB15722 | CYNK-001 | 1 / 2 | Withdrawn | 1 |
DB00853 | Temozolomide | 1 / 2 | Completed | 1 |
DB07232 | Veliparib | 1 / 2 | Completed | 1 |
DB00074 | Basiliximab | 2 | Completed | 1 |
DB00112 | Bevacizumab | 2 | Completed | 3 |
DB05827 | G207 | 2 | Not Yet Recruiting | 1 |
DB05036 | Grn163l | 2 | Terminated | 1 |
DB15412 | LB-100 | 2 | Completed | 1 |
DB01601 | Lopinavir | 2 | Terminated | 1 |
DB06132 | Nivolumab | 2 | Withdrawn | 1 |
DB09035 | Nivolumab | 2 | Withdrawn | 1 |
DB05374 | Rindopepimut | 2 | Completed | 1 |
DB00503 | Ritonavir | 2 | Terminated | 1 |
DB00853 | Temozolomide | 2 | Completed | 2 |
DB12056 | Trebananib | 2 | Completed | 1 |
DB05299 | Keyhole limpet hemocyanin | 3 | Completed | 1 |
DB05374 | Rindopepimut | 3 | Completed | 1 |
DB00020 | Sargramostim | 3 | Completed | 1 |
DB00853 | Temozolomide | 3 | Completed | 1 |
DB00853 | Temozolomide | Not Available | Withdrawn | 1 |